Lexaria Bioscience Corp (LEXX)
2.98
-0.51
(-14.61%)
USD |
NASDAQ |
May 02, 16:00
3.02
+0.04
(+1.34%)
After-Hours: 20:00
Lexaria Bioscience Market Cap: 38.40M for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 38.40M |
| May 01, 2024 | 44.97M |
| April 30, 2024 | 39.82M |
| April 29, 2024 | 31.70M |
| April 26, 2024 | 30.28M |
| April 25, 2024 | 28.22M |
| April 24, 2024 | 28.35M |
| April 23, 2024 | 28.86M |
| April 22, 2024 | 29.19M |
| April 19, 2024 | 28.35M |
| April 18, 2024 | 28.99M |
| April 17, 2024 | 30.15M |
| April 16, 2024 | 29.77M |
| April 15, 2024 | 25.64M |
| April 12, 2024 | 27.32M |
| April 11, 2024 | 32.34M |
| April 10, 2024 | 34.28M |
| April 09, 2024 | 34.79M |
| April 08, 2024 | 37.51M |
| April 05, 2024 | 38.65M |
| April 04, 2024 | 40.42M |
| April 03, 2024 | 43.21M |
| April 02, 2024 | 43.97M |
| April 01, 2024 | 43.33M |
| March 28, 2024 | 46.00M |
| Date | Value |
|---|---|
| March 27, 2024 | 47.01M |
| March 26, 2024 | 48.02M |
| March 25, 2024 | 50.05M |
| March 22, 2024 | 43.97M |
| March 21, 2024 | 43.59M |
| March 20, 2024 | 46.88M |
| March 19, 2024 | 50.68M |
| March 18, 2024 | 43.08M |
| March 15, 2024 | 49.42M |
| March 14, 2024 | 48.78M |
| March 13, 2024 | 55.75M |
| March 12, 2024 | 52.96M |
| March 11, 2024 | 77.42M |
| March 08, 2024 | 68.13M |
| March 07, 2024 | 61.94M |
| March 06, 2024 | 55.50M |
| March 05, 2024 | 41.87M |
| March 04, 2024 | 37.16M |
| March 01, 2024 | 36.17M |
| February 29, 2024 | 42.74M |
| February 28, 2024 | 31.56M |
| February 27, 2024 | 29.71M |
| February 26, 2024 | 27.97M |
| February 23, 2024 | 26.98M |
| February 22, 2024 | 27.71M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.639M
Minimum
May 10 2023
81.52M
Maximum
May 10 2019
26.82M
Average
24.31M
Median
Dec 08 2020
Market Cap Benchmarks
| Aurinia Pharmaceuticals Inc | 737.98M |
| Sunshine Biopharma Inc | 0.834M |
| Acasti Pharma Inc | 28.48M |
| Edesa Biotech Inc | 14.45M |
| Xenon Pharmaceuticals Inc | 3.244B |
Market Cap Related Metrics
| PS Ratio | 66.33 |
| Price to Book Value | 5.889 |
| Price | 2.98 |
| Earnings Yield | -22.82% |